Market Reactions: Earnings Reports Drive Mixed Stock Performance

Palantir Soars on Strong Q4 Earnings

Palantir's stock increased by 11% after reporting fourth-quarter earnings that surpassed analyst expectations.

The AI-powered software provider reported adjusted earnings of 25 cents per share, exceeding the 23 cents anticipated by LSEG-polled analysts.

Revenue reached $1.41 billion, comfortably above the $1.33 billion consensus estimate.

Merck Shares Dip on Modest 2026 Outlook

Merck's shares decreased by approximately 1% after the company provided a modest 2026 outlook.

This outlook anticipates the loss of some drug patent protections and increased competition from generic versions. The pharmaceutical company projected 2026 revenue between $65.5 billion and $67 billion, which is below the $67.6 billion expected by LSEG-polled analysts.

PepsiCo Declines Despite Strong Quarterly Results

PepsiCo reported fourth-quarter earnings and revenue that exceeded analyst expectations.

Despite these positive results, the company's shares decreased by approximately 1% due to anticipated declines in sales volumes.

Pfizer Outlook Overshadows Earnings Beat

Pfizer's shares decreased by 1% after the company reaffirmed a modest outlook.

This modest outlook overshadowed its reported quarterly earnings and revenue, which had both surpassed analyst expectations.